Advances in the Generation of Genetically Modified Animal Models: International Course & Symposium, Institut Pasteur de Montevideo (Uruguay), 7-18 September 2015

Advances in the Generation of Genetically Modified Animal Models: International Course & Symposium, Institut Pasteur de Montevideo (Uruguay), 7-18 September 2015
Advances in the Generation of Genetically Modified Animal Models: International Course & Symposium, Institut Pasteur de Montevideo (Uruguay), 7-18 September 2015

The International Society for Trangenic Technologies (ISTT) proudly co-sponsors the International Course & Symposium on Advances in the Generation of Genetically Modified Animal Models, to be held at the Institut Pasteur de Montevideo (Uruguay), organized by ISTT Members Martina Crispo (Unidad de Animales Transgénicos y Experimentación, UATE, Institut Pasteur de Montevideo) and Alejo Menchaca (Instituto de Reproducción Animal de Uruguay, IRAUy), on 8-15 September 2015.

The aim is to offer a training course of excellence for researchers and technicians working in animal transgenic field. The topics will be focused on both the basic knowledge and the latest advances in transgenic technologies. The course consists of a 1st week of lectures sessions and a 2nd week of practical sessions. In addition, a mini symposium (11-12 September) is organized in order to extend the impact of the presence of the professors to other researchers, technicians and posgraduate students. Current programs for the COURSE and MINI-SYMPOSIUM.

Confirmed speakers attending this Course and mini-Symposium include:

  • Michel Cohen-Tannoudji, IPParis, France
  • Francina Langa, IP Paris, France, ISTT member
  • Ignacio Anegón, INSERM, Nantes, France, ISTT member
  • Lluis Montoliu, CNB, Spain, ISTT member
  • Jorge Sztein, consultant, Spain
  • Sylva Haralambous, HPI, Greece, ISTT member
  • Naomi Nakagata, CARD, Kumamoto U, Japan, ISTT member
  • Charles Long, Texas A&M University, USA
  • Daniel Salamone, Fagro, UBA, Argentina
  • Adrian Mutto, UNSM, Argentina
  • Marcelo Rubinstein, INGEBI, Argentina, ISTT member
  • Marcelo Bertolini, UNIFOR, Brazil

Local professors and instructors include:

  • Magdalena Cárdenas, IP Montevideo, Uruguay
  • Ana Paula Mulet, IP Montevideo, Uruguay
  • Geraldine Schlapp, IP Montevideo, Uruguay, ISTT member
  • María Noel Meikle, IP Montevideo, Uruguay, ISTT member
  • Gabriel Fernández, IP Montevideo, Uruguay
  • Ana Paula Arévalo, IP Montevideo, Uruguay
  • Martina Crispo, IP Montevideo, Uruguay, ISTT member
  • Pedro C. dos Santos, IRAUy, Uruguay
  • Natalibeth Barrera, IRAUy, Uruguay
  • Federico Cuadro, IRAUy, Uruguay
  • Alejo Menchaca, IRAUy, Montevideo, Uruguay, ISTT member

People interested in participating in this COURSE must send the COURSE Application Form to tgcourse2015@pasteur.edu.uy
A maximum of 20 students will be accepted for the COURSE taking into account personal qualifications.
There is no registration fee for the COURSE. Support for accommodation, per diem and local transportation will be provided to all participants from abroad. Travel expenses are not included.
People interested in participating in the MINI SYMPOSIUM must send the SYMPOSIUM Registration Form to tgcourse2015@pasteur.edu.uy
SYMPOSIUM fee is U$S 100.

SAVE THE DATES!
Deadline for COURSE applications is June 28th
Deadline for SYMPOSIUM registrations is July 19th
For any further information contact: tgcourse2015@pasteur.edu.uy
www.pasteur.edu.uy/index.php/en/futurecourses

 

TT2014 abstracts: submission deadline is approaching (30 June)

TT2014 abstracts: submission deadline is approaching (30 June)
TT2014 abstracts: submission deadline is approaching (30 June)

From the International Society for Transgenic Technologies (ISTT) we warmly invite and encourage you all to submit your most recent and exciting results and developments in animal transgenesis to be presented at the forthcoming 12th Transgenic Technology (TT2014) meeting, which will be held in Edinburgh, Scotland, UK, on 6-8 October 2014. Deadline for submitting abstracts for the TT2014 meeting is June 30.
To submit an abstract please visit this TT2014 meeting web page.

All TT2014 participants are encouraged to submit their work as an abstract for poster presentation at the TT2014 meeting. Authors are requested to submit an abstract with the following requirements:

  • Title (max. 25 words)
  • Name authors and affiliations (first author is the presenting author).
  • Text of the communication (max. 400 words).
  • Abstracts should be submitted no later than June 30, 2014.

Accepted abstracts will be published in the scientific journal Transgenic Research (Springer), to which the ISTT is associated.

Posters
Posters will be on display in the exhibition area throughout the duration of the meeting. Poster boards are 1.00m wide x 2.00m high and we recommend posters do not exceed 1.50m in length. A supply of Velcro tabs will be available at the venue. No screws or double-sided adhesive tape will be allowed due to the damage they can cause to the boards.

Best Poster Awards
All posters presented at the TT2014 meeting will be eligible for one of the ISTT Best Poster Awards, generously sponsored by Charles River, Inc.

Oral Presentations
A limited number of abstract submissions will be selected and invited to present their findings in the form of a short oral presentation within the main meeting program. Should you be interested in being considered to speak at the meeting please select the appropriate option when submitting your abstract.

Abstracts are invited on all aspects of Transgenic Technologies, including the conference themes as listed below:

  • New technologies in animal transgenesis
  • Embryo stem cells
  • Target nucleases or Editing nucleases (ZFNs, TALENs, CRISPRs)
  • Large-scale phenotyping
  • Animal Biotechnology
  • Imaging with transgenic animals
  • Mouse models of human disease
  • Zebrafish models of human disease and transgenesis
  • Animal ethics and welfare

We are looking forward to receiving your exciting works to discuss the latest development on animal transgenesis!. See you all in Edinburgh!

Highlights of the TT2014 meeting in Edinburgh: a conference you can’t miss!

The TT2014 meeting in Edinburgh (6-8 October 2014)
The TT2014 meeting in Edinburgh (6-8 October 2014)

This year’s ISTT main activity is the 12th Transgenic Technology conference, the TT2014 meeting, which will be held in Edinburgh, Scotland, UK, on 6-8 October 2014, followed by a 2-day hands-on workshop on basic zebrafish transgenesis techniques. The ISTT promotes the TT meetings every 18 months, these being the most important activity of our Society. This year, the local Organizers and advisory committees, commanded by Douglas Strathdee, need to be praised for preparing a most appealing and interesting program, addressing hot topics, current and most up-to-date issues actively discussed nowadays by the transgenic animal community. Talks that will be presented by the most active and prestigious scientists in our field.

Why you shouldn’t miss the TT2014 meeting?

  • If you are interested in the new transgenic methods associated to nucleases (ZFNs, TALENs and CRISPRs-Cas9) there will be plenty of interesting talks where these new fantastic tools will be presented and discussed, directly by the key players in this rapidly-evolving field, including: Rudolf Jaenisch, William Skarnes, Angelika Schnieke, Kai Schönig, Ignacion Anegon, Pawel Pelczar, Francis Stewart, Keith Joung and Feng Zhang. And, most likely, these techniques will be referred and cited in many additional talks too, including the round table discussion about the future of transgenic core facilities, chaired by James Bussell.
  • If you are interested in ES cell biology and in innovative uses of ES cells and associated technologies there will be unique talks delivered by Jos Jonkers, Austin Smith, Ian Chambers, Janet Rossant and Alex Joyner
  • If you are interested in phenotyping your mouse animal models there will be fantastic talks delivered by Jacqueline White, Stephen Murray, David Adams, Daniel Murphy, Anna-Katerina Hadjatonakis and Vasilis Ntziachristos
  • If you are interested in non-rodent, large mammals and birds, animal models there will be great talks by James Murray, Angelika Schnieke, Mike McGrew and Adrian Shermann
  • If you are interested in rats there will be compelling talks by Kai Schönig and Ignacio Anegon
  • If you are interested in zebrafish animal models there will be fascinating talks by Stephen Ekker, Koichi Kawakami, Keith Joung and Elizabeth Patton
  • If you are interested in animal welfare and 3Rs, in the best use of our laboratory animals, there will be captivating talks by Peter Hohenstein, Sara Wells and Jan-Bas Prins.

Therefore, there will be really engaging talks interesting to everyone in our field. This is why you shouldn’t miss this great and unique opportunity!.

Register now for the TT2014 meeting. Submission of abstracts will be accepted up to June 30. Early-Bird registration at reduced fees will be promoted up to July 31. ISTT members are entitled to reduced fee registration.

See you all in Edinburgh in October!

 

SALAAM: Sharing Advances on Large Animal Models

SALAAM: Sharing Advances on Large Animal Models
SALAAM: Sharing Advances on Large Animal Models

The EU-COST action SALAAM (Sharing Advances on Large Animal Models) was launched yesterday in Brussels, at a kick-off meeting attended by most of its members. This 4-year EU-COST action is currently formed by 17 countries and more than 44 participants, including many experts in the fields of animal genetics, physiology, transgenesis, bioethics, welfare and animal science, with a focus on large (i.e. non-rodent) animal models. This EU-COST action is chaired by Prof Eckhard Wolf (Germany) and vice-chaired by Dr. Pascale Chavatte-Palmer (France) and it includes various ISTT members such as Bruce Whitelaw (UK), Zsuzsanna Bosze (Hungary), András Dinnyes (Hungary), Cesare Galli (Italy) and Lluis Montoliu (Spain). In addition, another participant in this EU-COST action, Angelika Schnieke (Germany) is one of the invited speakers at the forthcoming 12th Transgenic Technology (TT2014) meeting to be held in Edinburgh (Scotland, UK).

EU-COST (European Cooperation in Science and Technology) is one of the oldest European initiatives in Science, an intergovernmental framework for European Cooperation in Science and Technology, allowing the coordination of nationally-funded research on a European level. SALAAM EU-COST action, as its acronym indicates, aims to sharing advances in genetic engineering and phenotyping of non-rodent mammals to develop predictive animal models for translational medicine. While recognizing the value of small and most popular animal models (mouse, rat, zebrafish, Drosophila, C. elegans, …) and its powerful genetics for increasing our knowledge on complex biological systems and for proof-of-concept-type experiments, this EU-COST action SALAAM focuses on large (i.e. non-rodent) mammalian models, since these may bridge the gap between proof-of-concept studies and more effective clinical trials, leading to better translational animal models for the study of human diseases. The research projects undertaken using rodent and non-rodent animal models should not be perceived as competition or opposed initiatives, rather as complementary studies, where each animal species is selected according to its particular value and expected benefits for the ultimate goal, that is, our understanding on the function of the mammalian (i.e. human) genome and the eventual development of effective treatments for many human diseases. During the course of this EU-COST action several conferences and training workshops will be organized, open to anyone interested in the field, to discuss about (1) new technologies (including the application of genome editing nucleases, i.e. CRISPR-Cas, for the generation of improved genetically altered animal models); (2) defining best animal models for specific phenotyping studies; (3) creation of databases for sharing information on animal models creates, tissues available and protocols; and (4) animal welfare, bioethics and communication to the public. All these conferences and training courses will be adequately advertised through the ISTT web site.

At the International Society for Transgenic Technologies (ISTT) we care about the generation and the analysis of “all” genetically altered animals, not only focused in the classical rodent models, but also including the work done with other species, with large animal models, in livestock. In this regard, the ISTT has been traditionally supporting conferences on non-rodent transgenic animals, organized in Tahoe by ISTT Member Jim Murray (UC Davis, USA) and has promoted a web page within the ISTT web site where most of the advances on livestock and other non-rodent genetically modified animal resources are shared. At the next 12th Transgenic Technology (TT2014) meeting, which will be held in Edinburgh on 6-8 October 2014, the Conference Organizers (Douglas Strathdee-Chair, Peter Hohenstein and Bruce Whitelaw) have scheduled a session on animal biotechnology, where the recent work accomplished using large animal models will be discussed. In addition, immediately following the TT2014 meeting, a hands-on workshop on zebrafish transgenesis methods will be offered to interested participants.

Meeting report: Promoting the international exchange of mouse mutant resources

Infrafrontier-IMPC workshop: Promoting the international exchange of mouse mutant resources, Munich, Germany, 8-9 May 2014
Infrafrontier-IMPC workshop: Promoting the international exchange of mouse mutant resources, Munich, Germany, 8-9 May 2014

This is a brief meeting report on the INFRAFRONTIER /IMPC workshop: Promoting the international exchange of mouse mutant resources, which was held in Munich, Germany, on 08-09 May 2014.
As indicated in the corresponding Infrafrontier web page: “The main objectives of the workshop were to discuss how to simplify the international exchange of mouse mutant resources and to define the procedural changes to achieve it, to review the key issues facing the mouse community and mouse repositories as well as focus on IP issues and to present best practices in sharing research tools. The workshop was targeted at the directors of major mouse repositories, IP and technology transfer experts, representatives of scientific journals and funders and attracted the attention of 70 participants.” Delegates from major mouse repositories (JAX, MMRRC, EMMA, CMMR, RIKEN BRC, CARD, MARC), mouse international projects and consortia (EUCOMM, EUCOMMTOOLS, KOMP, KOMP2, IKMC, IMPC, KMPC), other related consortia (SGC), scientific journals (Nature, PLOS), funding agencies (NIH), companies (BioDoc, Charles River, AddGene), associations (AMMRA, AMPC, FELASA, EARA), TTOs and lawyers from numerous institutions and end-users gathered to discuss about how to best promote the international exchange of mouse mutant resources.

This workshop was funded by the EC FP7 InfraCoMP project. InfraCoMP’s main objective is to coordinate the collaborative efforts between the Infrafrontier Research Infrastructure and the International Mouse Phenotyping Consortium (IMPC). The scope of this Infrafrontier-IMPC workshop in Munich included various major topics, such as:

  • to discuss about simplified procedures to effectively exchange mouse mutant resources among repositories and between repositories and end-users/customers, trying to review and fix all restrictions preventing from adequately sharing major mouse mutant resources.
  • to review the key issues currently faced by the mouse community and mouse repositories, including emerging new genome editing technologies (ZFNs, TALENs, CRISPRs) and the role of mouse archives in the international exchange of mouse mutant resources
  • to discuss on IP issues and the administrative paperwork usually associated with any transactional international negotiation involving licenses and MTAs
  • to showcase best practices, examples of successful sharing research tools that could be applied on sharing mouse mutant resources

This workshop represented a continuation towards the eventual application of the agreements included in the so-called Rome Agenda, published in 2009 (Schofield et al. 2009, Nature) where the major headlines, best practices and recommendations concerning the deposit and sharing of biological resources, including mice, ES cells and germplasm, under the least restrictive terms possible, had been already discussed and identified but, unfortunately, not sufficiently widespread nor systematically followed, in spite of new initiatives adopted by some funding agencies, enforcing public-access policies for materials associated with projects funded by the NIH or the Wellcome Trust in order to receive the allocated funds.

The impact of the new genome editing technologies on current mouse consortia and mouse archives was discussed at length and in depth, from various angles and by different speakers. It is obvious that a new logic has emerged, the updated mouse genetics toolbox and its widespread among scientists enables them to generate their mouse mutants of interest through alternative, often faster approaches. Instead of considering the new endonuclease-mediated mutations solely a threat for traditional approaches, based on ES cell clones (however using higher genetic and quality-controlled standards), it was finally interpreted as an opportunity for mouse consortia and repositories. For example, the easier and faster generation of new mouse mutations could help finishing the functional annotations of the mouse genome, for all these loci that could not be targeted or, if targeted, did not result in the corresponding mouse strain through IKMC-IMPC current approaches.

The description of innovative shipment methods, for refrigerated biological materials, or using dry-ice, as compared to the standard but more complex liquid-nitrogen dry shippers was also discussed in order to make the distribution of mouse mutant resources cheaper and easier. The new set of sperm and oocyte cryopreservation methods and the optimized associated IVF procedures, as reported by CARD, Kumamoto University, in Japan, have also greatly contributed to promote the international exchange of mouse mutant resources, avoiding the always difficult and expensive shipment of live research laboratory animals.

The legal agreements, such as Material Transfer Agreements (MTAs), governing the access to mouse mutant resources were also discussed extensively. The complexity of some of these MTAs and the often long administrative process involved for executing them, unnecessarily extends the time required to access to a given mouse mutant strain deposited in a major repository for academic use. Interesting analyses of common practices observed within the international mouse community and applied by mouse consortia were presented (Bubela et al. 2012; Mishra and Bubela, 2014). The overall recommendation was, whenever possible, avoid using specific MTAs and favor the unrestrictive distribution of mouse resources through simpler “conditions of use”, as regularly applied by The Jackson Laboratory (JAX) to all their mouse strains, and by EMMA-INFRAFRONTIER, for mouse lines non-associated to specific MTAs, in order also to reduce the administrative time to the minimum. In case MTAs should be included, for academic non-commercial use, the recommendations discussed were to simplify, and unify, the document as much as possible, ideally without requesting to disclose the field of use, without imposing reach through on modifications of the received materials and clearly defining third-party use after permission has been obtained. Attribution should also be clearly encouraged. Examples of simplified MTAs, also including useful institutional versions of these agreements, can be found at KOMP. The model deployed by AddGene, a non-profit organization dedicated to efficiently distribute plasmids among the scientific community, using also simple MTA procedures, was also presented as an example of successful solution.

Overall, this intense 2-day Infrafrontier-IMPC workshop fulfilled its aims and expectations. All stakeholders in the field could openly express their opinions, fears, opportunities, problems and solutions. The Organizers should be praised for their selection of speakers, topics and participants. Now it will be the time for the most difficult part: converting the agreements and recommendations into realities, while ensuring that researchers in academia, using mouse mutant resources, have an easier, simpler and faster access to mice and/or their associated products, for the benefit of science, and knowledge advance.

Infrafrontier-IMPC workshop: Promoting the international exchange of mouse mutant resources, Munich, Germany, 8-9 May 2014
Infrafrontier-IMPC workshop: Promoting the international exchange of mouse mutant resources, Munich, Germany, 8-9 May 2014

Submit your abstract(s) to the TT2014 meeting in Edinburgh: 30 June

Submit your abstract(s) to the TT2014 meeting in Edinburgh: 30 June
Submit your abstract(s) to the TT2014 meeting in Edinburgh: 30 June

The submission of abstracts for the 12th Transgenic Technology (TT2014) meeting, to be held in Edinburgh (Scotland, UK), on 6-8 October, is OPEN. All TT2014 participants are encouraged to submit their work as an abstract for poster presentation at the TT2014 meeting. Authors are requested to submit an abstract with the following requirements: Title (max. 25 words), Name authors and affiliations (first author is the presenting author), and, Text of the communication (max. 400 words). Abstracts should be submitted no later than June 30, 2014. Accepted abstracts will be published in the scientific journal Transgenic Research (Springer), to which the ISTT is associated.

Posters
Posters will be on display in the exhibition area throughout the duration of the meeting. Poster boards are 1.00m wide x 2.00m high and we recommend posters do not exceed 1.50m in length. A supply of Velcro tabs will be available at the venue. No screws or double-sided adhesive tape will be allowed due to the damage they can cause to the boards. All presented Posters at the TT2014 meeting will be entitled to the Best Poster Awards, generously sponsored by Charles River.

Oral Presentations
A limited number of abstract submissions will be selected and invited to present their findings in the form of a short oral presentation within the main meeting program. Should you be interested in being considered to speak at the meeting please select the appropriate option when submitting your abstract.

Abstracts are invited on all aspects of Transgenic Technologies, including the conference themes as listed below:

  • New technologies in animal transgenesis
  • Embryo stem cells
  • Target nucleases or Editing nucleases (ZFNs, TALENs, CRISPRs)
  • Large-scale phenotyping
  • Animal Biotechnology
  • Imaging with transgenic animals
  • Mouse models of human disease
  • Zebrafish models of human disease and transgenesis
  • Animal ethics and welfare

The 3rd ISTT Young Investigator Award goes to Feng Zhang

The 3rd ISTT Young Investigator Award goes to Feng Zhang (picture kindly provided by the Broad Institute of MIT and Harvard)
The 3rd ISTT Young Investigator Award goes to Feng Zhang (picture kindly provided by the Broad Institute of MIT and Harvard)

The International Society for Transgenic Technologies (ISTT) is pleased to announce the awardee for the third (3rd) ISTT Young Investigator Award, generously sponsored by inGenious Targeting Laboratory (iTL). After careful evaluation of the nominated candidates, the Award Committee selected Dr. Feng Zhang (Broad Institute of MIT and Harvard; the McGovern Institute for Brain Research at MIT; and the Departments of Brain and Cognitive Sciences, and Biological Engineering at MIT, Cambridge, MA, USA).

Zhang’s recent outstanding work in the development of the CRISPR-Cas technology has set the pace in this highly competitive field. Among his many seminal contributions to CRISPR-Cas technology is the engineering of the RNA-guided nuclease Cas9 for use in editing the mammalian genome. This and his other recently published works have clearly impacted the field of transgenic technologies. Moreover, Zhang has encouraged transparency in the development of CRISPR-Cas technology and has made his work accessible for use by the broader scientific community.

Zhang was born in Shijiazhuang (Hebei Province, China) in 1981 and moved to the USA in 1993, where he was educated and trained at various institutes, including the Human Gene Therapy Research Institute (Des Moines, IA, 1997-99) as a high school student and the Department of Chemistry and Chemical Biology (2000-2004) at Harvard University (Cambridge, MA), where he obtained before his A.B. degree in Chemistry and Physics. He then moved to Stanford University (Stanford, CA) to conduct his PhD work (2004-2009) under the supervision of Dr. Karl Deiseroth in the Department of Bioengineering, obtaining his Ph.D. degree in Chemistry in 2009. As a graduate student, Dr. Zhang worked with Deisseroth to invent a set of technologies for dissecting the functional organization of brain circuits, using light-sensitive proteins from green algae and other microbes to develop a new “optogenetic” toolbox for controlling the activity of neurons in live organisms with light.

After finishing his Ph.D., he returned to Cambridge, MA, as a Junior Fellow at the Harvard Society of Fellows (2009-2010) and began his own laboratory at the Massachusetts Institute of Technology (MIT) in 2011 as an Assistant Professor. He has achieved great success and has shown strong leadership as a Core Member of the Broad Institute of MIT and Harvard; as an Investigator of the McGovern Institute for Brain Research at MIT; and as a W. M. Keck Career Development Professor in Biomedical Engineering, in the Departments of Brain and Cognitive Sciences and Biological Engineering at MIT. Dr. Zhang provides an excellent example of how scientific questions lead to the development and utilization of new technologies, as is reflected by his widespread research as an investigator at these various institutions.

Dr. Zhang has already received numerous prizes, awards and distinctions, including: the Perl/UNC Prize in Neuroscience, the NIH Director’s Pioneer Award, technology innovation awards from the McKnight and Damon Runyon Foundations, and the NSF Alan T. Waterman Award. He was also recently named one of the “Brilliant Ten” top minds in science by Popular Science, and also named by Nature as one of their top 10 scientists who mattered in 2013. Dr. Feng Zhang is also a co-founder of the popular non-profit molecular biology web app everyVECTOR.

The following articles represent only some of his recent research published in the last two years, highlighting his most recent contributions to the CRISPR-Cas field and related publications on other editing nucleases systems. These publications have had a tremendous impact in the animal transgenesis field and have rapidly become highly sought-after references for subsequent studies.

The 2014 ISTT Young Investigator Award Committee was formed by Dr. Lluis Montoliu (President of ISTT), Dr. Benoît Kanzler (Vice-President of ISTT, Chair) and Dr. Paul Sheiffele (iTL CEO). Dr. Feng Zhang was nominated by ISTT Member Dr. Jan Parker-Thornburg (MD Anderson Cancer Centre, Houston, TX, USA).

Dr. Feng Zhang will attend the next 12th Transgenic Technology (TT2014) meeting in Edinburgh (Scotland, UK, 6-8 October 2014) where he will receive the corresponding diploma and will deliver a talk summarizing the scientific achievements that led him to receive this 3rd ISTT Young Investigator Award, sponsored by inGenious Targeting Laboratory (iTL).

Download this Press Release as a PDF document

Advertising the TT2014 meeting from your institutions: put one of these Posters!

12th Transgenic Technology (TT2014) meeting, Edinburgh, Scotland, UK, 6-8 October 2014
12th Transgenic Technology (TT2014) meeting, Edinburgh, Scotland, UK, 6-8 October 2014

The next ISTT meeting will be held in Europe this year. The 12th Transgenic Technology (TT2014) meeting, will take place in Edinburgh, Scotland, UK, on 6-8 October 2014, organized by ISTT members Douglas Strathdee (chair), Peter Hohenstein and Bruce Whitelaw, and hosted by three Scottish research institutes and the University of Edinburgh: the Roslin Institute; the Institute of Genetics and Molecular Medicine and the Beatson Institute for Cancer Research. The TT2014 meeting will be followed by the 2-day hands-on workshop “An Introduction to Zebrafish Transgenesis“, on 8-10 October 2014.

An outstanding group of invited speakers have confirmed their participation at the TT2014 meeting. Abstract submissions and application for the ISTT registration awards (for ISTT members) deadlines merge on 30 June 2014. Early bird registration deadline at reduced fees is 31 July 2014. A number of submitted abstracts will be selected for oral presentation on topics including:

  • new technologies in transgenesis
  • pluripotential stem cells
  • targeted nucleases and genome editing
  • models of human disease
  • animal ethics and welfare
  • large-scale phenotyping initiatives
  • animal biotechnology
  • in vivo imaging
  • zebrafish models and transgenesis

Douglas Strathdee and his colleagues have prepared the following collection of eight Posters to advertise the TT2014 meeting, illustrated with beautiful Edinburgh pictures. Please, help us announcing and disseminating the TT2014 meeting by putting one or several of these Posters at your centres, institutions, facilities, departments, universities. The TT meeting is a unique forum occurring every 18 months where to discuss the latest technical developments and applications on animal transgenesis. This is a conference that can’t be missed by anyone interested in this subject! Thanks for helping us advertise the TT2014 meeting!

TT2014 Poster version 1
TT2014 Poster version 1

TT2014 Poster version 1 (A4 format)
TT2014 Poster version 1 (A3 format)

TT2014 Poster version 2
TT2014 Poster version 2

TT2014 Poster version 2 (A4 format)
TT2014 Poster version 2 (A3 format)

TT2014 Poster version 3
TT2014 Poster version 3

TT2014 Poster version 3 (A4 format)
TT2014 Poster version 3 (A3 format)

TT2014 Poster version 4
TT2014 Poster version 4

TT2014 Poster version 4 (A4 format)
TT2014 Poster version 4 (A3 format)

TT2014 Poster version 5
TT2014 Poster version 5

TT2014 Poster version 5 (A4 format)
TT2014 Poster version 5 (A3 format)

TT2014 Poster version 6
TT2014 Poster version 6

TT2014 Poster version 6 (A4 format)
TT2014 Poster version 6 (A3 format)

TT2014 Poster version 7
TT2014 Poster version 7

TT2014 Poster version 7 (A4 format)
TT2014 Poster version 7 (A3 format)

TT2014 Poster version 8
TT2014 Poster version 8

TT2014 Poster version 8 (A4 format)
TT2014 Poster version 8 (A3 format)

A report on the 7th European Short Course on Laboratory Animal Science in Strasbourg, organized by Charles River

A report on the 7th European Short Course on Laboratory Animal Science in Strasbourg, organized by Charles River
A report on the 7th European Short Course on Laboratory Animal Science in Strasbourg, organized by Charles River

The 7th European Short Course on Laboratory Animal Science, organized by Charles River, just closed in Strasbourg, France, after three days of interesting presentations and discussions at the intersection between animal welfare, animal experimentation, current guidelines and legislation, biomedical research from academia and industry and society perception on these topics. The Organizers should be praised for the selection and variety of topics, as well as for the smooth and pleasant running of the entire course, which included an enjoyable visit to an old typical cellar from the Alsace region along with a wine-testing Gala dinner.

Several ISTT members participated in this event, including organizers (Cyril Desvignes, Jean Cozzi), members of the steering committee (Johannes Wilbertz), invited speakers (Belén Pintado, Yann Herault, Ignacio Anegon, Lluís Montoliu), and participants (Marcello Raspa, Ferenc Erdelyi, Gabor Szabo,…) among other.

During this course, the recent EU Directive 2010/63 on the protection of animals used in research and its implication on the use of animals in biomedical research and policies throughout Europe was discussed, from different angles, by Magda Chlebus, Gill Fleetwood, Thierry Decelle, Patri Vergara and Belén Pintado. Topics covered included the new training courses and competencies to work with experimentation animals in Europe, the animal-welfare bodies and the current understanding of the 3R’s paradigm. Javier Guillén compared, side by side, the new EU Directive with the current Guide in the US and highlighted their many coincidences, suggesting that a combined use of both documents would be ideal for the adoption of successful animal care and use programs. Jan-Bas Prins, current president of FELASA, presented his view of the field of laboratory animal sciences, before the implementation of this new EU Directive, as an opportunity and a positive challenge to interface and exchange knowledge with many other players involved.

Health monitoring programs, rodent microbiologic surveillance, methods employed to detect all these pathogens robustly in laboratory animal facilities and the updated recommendations from FELASA, recently published in Laboratory Animals, were presented by William Shek, Guy Mulder, Stéphanie Durand and Axel Kornerup Hansen. Operational and technical aspects of animal facilities were discussed by Alberto Gobbi and Peter Dockx, whereas the issues related with occupational health and safety program evaluations were presented by Jann Hau.

Examples of the use of rodent animal models in biomedical research, in academia, by James Di Santo and Andrea Bertotti, as well as in the industry, by Joyce L. Young, were discussed. The importance of genetic quality in mouse research as well as the complexity of mouse genome and the impact of the genetic background on phenotypes was presented by Charles Miller and Lluís Montoliu, respectively. The procedures conducted at the International Mouse Phenotyping Consortium (IMPC) as well as the challenges they encountered during the deployment of this impressively large enterprise were presented and discussed by Sara Wells and, by the local representative, Yann Herault, Director of the French Mouse Clinic, ICS, in Strasbourg, who delivered the closing talk.

The newest technologies in stem cell biology and animal transgenesis were also present at this 7th Short Course. Hongkui Deng summarized the most innovative approach he devised to prepare induced-pluripotent cells from somatic cells, using a cocktail of four chemicals, four molecules that mimicked the induction signals described by Shinya Yamanaka. The new logics for the production of targeted genetic modifications, using editing or engineered nucleases (Meganuclease, ZFNs, TALENs, CRISPRs) in mice and rats was presented by Ralf Kuehn and Ignacio Anegon, respectively.

The choice of rodent anaestesia protocols was discussed by Aurelie Thomas, whereas the various methods for euthanasia in rodents were presented by Huw Golledge. On the last day, Aurora Bronstad summarized the work done at the AALAS-FELASA joint working group on harm-benefit analysis, whereas Katrina Gore highlighted the need for more robust analytical procedures in research protocols involving animal experimentation, in order to optimize the rate of success of pre-clinical drugs.

In summary, the 7th Edition of this biennial Charles River Short Course on Laboratory Animal Science in Europe, attended by some 120 participants, was an excellent opportunity to update information related to animal welfare, EU legislation and transposition difficulties in various countries, newest technologies, mouse genomics and genetics, large mouse consortia and numerous important topics that are relevant for animal facility managers, researchers, veterinarians and anyone else interested in the best use of animals in experiments, according to current laws and recommendations.

More than 27,000 messages on animal transgenesis available to ISTT members through ISTT_list and tg-l archives

More than 27,000 messages on animal transgenesis available through ISTT_list and tg-l archives
More than 27,000 messages on animal transgenesis available through ISTT_list and tg-l archives

One of the most important assets of the International Society for Transgenic Technologies (ISTT), is the amount of information on animal transgenesis accummulated through the archives of the ISTT_list and tg-l email lists. Currently, more than 27,000 messages are fully available to ISTT members, conveniently organized in searchable and dynamic archives. The traditional transgenic-list (tg-l), operative since 1996 and offered from the ISTT web server since the end of 2011, has distributed over 22,000 messages since then, whereas the ISTT_list, associated and born with our Society in 2006, has disseminated some 5,000 messages, discussing both lists on almost each and every topic, issue or situation related directly or indirectly with animal transgenesis. All this endless information resource is fully available to ISTT members, through powerful search engines. Non-ISTT members subscribing to tg-l have access only to the most recent messages distributed through the tg-l, using the simple search engine, which allows simple searches and outputs the 50 most recent messages discussed on the subject of interest. In contrast, ISTT members have access to more sophysticated searching engines and the output always contains all messages archived on the matter investigated.

Obtaining granted access to these rich sources of information is very easy and cheap. Simply apply for ISTT membership! Submit now your application to become a member of the ISTT and you will get immediate and full access to all these messages.